Cafri C; Zahger D; Rosenshtein G, Kleshian I; Ilia R

Similar documents
Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam

Between Coronary Angiography and Fractional Flow Reserve

Georgios Pavlakis. Consultant Interventional Cardiologist. K.A.T. General Hospital of Athens, GREECE

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Annie Chou Internal Medicine PGY3 University of British Columbia. Rocky Mountain Internal Medicine Conference November 24, 2011

C. Thrombus burden according to TIMI thrombus grading system

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO

PROMUS Element Experience In AMC

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

ACI London Thrombectomy in STEMI. is the evidence clear? Brad Higginson International marketing manager

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

ΟΜΑΔΕΣ ΕΡΓΑΣΙΑΣ ΘΕΣ/ΝΙΚΗ 2013

No-reflow is defined as a failure to restore antegrade normal coronary flow despite appropriate treatment of coronary obstruction. The prevalence of t

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

DESolve NX Trial Clinical and Imaging Results

TCT mdbuyline.com Clinical Trial Results Summary

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Percutaneous Intervention of Unprotected Left Main Disease

Basics of Angiographic Interpretation Analysis of Angiography

Risk Factors for No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study

Side Branch Occlusion

Lessons learned From The National PCI Registry

New Insight about FFR and IVUS MLA

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

1. Diabetes mellitus (DM) is associated with worse clinical and angiographic outcomes even in acute myocardial Infarction (AMI) patients.

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Korea University Guro Hospital, Seoul, Korea * Chonnam National University Hospital, Gwangju, Korea

The Japanese ASPARAGUS Trial

Patient referral for elective coronary angiography: challenging the current strategy

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

LM stenting - Cypher

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

Strategies for PCI of SVG

Hon-Kan Yip, MD; Chiung-Jen Wu, MD; Morgan Fu, MD; Kuo-Ho Yeh, MD; Teng-Hung Yu, MD; Wei-Chin Hung, MD; and Mien-Cheng Chen, MD

PCI for Long Coronary Lesion

Predictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease

INTRODUCTION. Key Words:

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:

International Journal of Cardiology and Cardiovascular Research Vol. 1(1), pp , June,

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

Late stent thrombosis: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESc Institute of Cardiology Catholic University of Rome, Italy

Coronary angiography and PCI

IVUS vs FFR Debate: IVUS-Guided PCI

Minimalist immediate mechanical intervention in acute ST-segment elevation myocardial infarction: is it time to redefine targets?

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI

Clinical case in perspective. Cases from Poland

Abstract Background: Methods: Results: Conclusions:

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Trial Update- TOTAL. Jonathan Byrne

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

The grey zone of coronary interventions: Degenerated saphenous vein grafts

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia

Making the difference with Live Image Guidance

Primary Results of the Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement Study

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Update from Korea on the Lutonix SFA registry 12 month data

Protection of side branch is essential in treating bifurcation lesions: overview

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy

Unprotected LM intervention

Approach to Multi Vessel disease with STEMI

Bifurcation stenting with BVS

FFR and IVUS Guided DES Implantation in Long Diffuse Lesions

Correlates of Adverse Events During Saphenous Vein Graft Intervention With Distal Embolic Protection

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI Allen Jeremias, MD, MSc

For Personal Use. Copyright HMP 2013

Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction. A TIMI 14 Substudy

Α-Δ. ΜΑΤΡΟΓΙΑΝΝΗ ΚΑΡΔΙΟΛΟΓΟ AIMOΔΤΝΑΜΙΚΟ ΕΡΓΑΣΗΡΙΟ Γ.Ν.Θ. Γ. ΠΑΠΑΝΙΚΟΛΑΟΤ ΘΕΑΛΟΝΙΚΗ

Insights from the Magmaris Clinical Data: BIOSOLVE II and BIOSOLVE III 12 Month Follow Up

Total occlusion at ostial Left internal mammary graft with successful angioplasty and longterm patency result

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

Multiple PCI of SVG-LAD and SVG-OM graft vessel in a Bangladeshi patient starting 7 years after

CASE REPORTS: Filters to Prevent Distal Embolization during Coronary Artery Stenting: The Risk of Mousetrap

Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction

STEMI Primary Percutaneous Coronary Intervention

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

P1 - Posters - Interventional Cardiology

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital

STEMI ST Elevation Myocardial Infarction

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Rotarex mechanical debulking: The Leipzig experience in patients

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention

Intervention: How and to which extent is technology helping us?

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Transcription:

Primary Percutaneous Coronary Intervention and Large Thrombus Burden Lesio: A Questionable Impact of Mesh Covered Stent on the Frequency of No Reflow Cafri C; Zahger D; Rosehtein G, Kleshian I; Ilia R Soroka Medical Center and Faculty of Health Sciences. Ben Gurion University of the Negev Beer Sheva. Israel

Background Multiple mechanical and pharmacological strategies have failed to prevent no reflow during primary PCI The mesh covered stent is a new technology proposed for the prevention of distal embolization during primary PCI

Background The size and morphology of coronary thrombus are important predictors of no reflow The impact of mechanical and pharmacological therapies on the prevention of no reflow in lesio containing a large thrombus burden is uncertain.

AIMS To investigate the influence of the mesh covered stent on the frequency of angiographic no reflow in selective STEMI patients characterized by a large thrombus burden during primary PCI

Methods Retrospective single center study Population: 61 pts with STEMI treated with primary PCI characterized by TIMI Thrombus grade III Use of the mesh covered stent (Mguard) or BMS Analyzed data: Demographic, clinical, angiographic and angioplasty variables

Methods Source of data: Electronic records and coronary angiography Patient selection Mguard: Identification of PPCI pts treated with Mguard Angiography review Selection of patients with TIMI thrombus III BMS: Randomized sample of 300 PPCI patie Angiography review Selection of patients with TIMI thrombus III

Methods Statistical Analysis SPSS 18 Univariate analysis Chi square for categorical variables t test for continuous variables Multivariate analysis Logistic Regression Model

Definitio No reflow: Traient or persistent reduction in TIMI flow grade after resolution of the flow limiting stenosis

Definitio TIMI thrombus grade TIMI 0: no angiographic evidence TIMI 1: Possible thrombus (reduced contrast deity, haziness, irregular contour TIMI 2: (small): dimeion < 1/2 vessel diameter TIMI 3: dimeion=1/2 to <2 vessel diameter TIMI 4: > 2 vessel diameter TIMI 5: total occlusion

Baseline Characteristics Mesh Covered Stent (33 p.) BMS (28p.) p value Age ( years) 54 ±11 59± 13 <0.05 Male (%) 88 89 Hyperteion (%) 71 75 Dyslipidemia (%) 58 43 Diabetes (%) 21 14 Smoking (%) 76 71 Symptoms-Device time (min.) 215 ±138 144 ±74 <0.05 Infarct artery=lad(%) 56 36 Baseline TIMI III (%) 12 25 Baseline RVD (mm) 3.5 ± 0.6 3.1 ± 0.4 Baseline DS (%) 98± 4 98 ±5

TIMI Thrombus Grade

Procedures Mesh Covered Stent (33 p.) BMS (28p.) p value Aspiration (%) 68 52 Pre-dilatation (%) 16 35 >1 stent implanted (%) 24 18 Total stent length (mm) 18 ±6 18±5 Maximal device size(mm) 3.3 ± 0.3 3.3± 0.4 Maximal dilatation pressure (atm) 17 ±3 16± 2

Procedural Results Mesh Covered Stent (33 p.) BMS (28p.) p value Final TIMI III flow (%) 96 90 Final TIMI flow 2.65 ± 0.5 2.64 ±0.6 Corrected TIMI frame count 18 ± 10 23 ± 9 0.04 Myocardial blush=3 46 33 Residual thrombus (%) 9 18 Distal Emboli (%) 7 12 Angiographic No Reflow (%) 0 14 0.02

Predictors of No Reflow: Multivariate Analysis p value OR 95% CI Mguard 0.9 1.1 0.98-1.02 Thrombus Score 4-5 0.8 1.3 0.07-25 Age (years) 0.09 1.08 0.98-1.22 Pain to Device Time (min) 0.6 0.99 0.98-1.02

Limitatio Retrospective study Small number of patients Differences in the size of thrombus between BMS and covered stent groups Value of multivariate analysis limited by the small number of patients

Conclusio The mesh covered stent when implanted in lesio containing large thrombus burden in the setting of PPCI is associated with better angiographic result including ctfc and no reflow. This association did not persist after adjustment and larger studies are necessary

Professional and non scientific opinion In imposible cases with large thrombus and high probability of no reflow the use of mesh covered stent alone or in combination with others techniques works and allows to obtain a reasonable angiographic result and some degree of satisfaction at the end of the procedure.

THANK YOU!!!

Angiographic predictors of no reflow Angiographic thrombus with: Greatest linear dimeion > 3 times the reference lumen diameter Abrupt cutoff pattern Accumulated thrombus proximal to the occlusion Yip HK, et al. Chest 2002;122:1322

High Thromboembolic Risk for No Reflow Floating thrombus proximal to the occlusion Persistent contrast medium distal to the obstruction Lumen diameter > 4.0 mm Yip HK, et al. Chest 2002;122:1322